India GlycolsBOM:500201 +2.09%71 Days Payable is 118.45 as of Mar. 2026, which is 15% below its 10-year median of 140.08. GuruFocus rates BOM:500201 with a GF Score™ of 71/100 and a GF Value™ of ₹755.34 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,552 Chemicals companies, India Glycols ranks better than 83.05% on this metric.
The historical rank and industry rank for India Glycols's Days Payable or its related term are showing as below:
BOM:500201'
s Days Payable Range Over the Past 10 Years
Min: 118.57 Med: 140.08 Max: 169.68
Current: 122.49
During the past 13 years, India Glycols's highest Days Payable was 169.68. The lowest was 118.57. And the median was 140.08.
BOM:500201's Days Payable is ranked better than 83.05% of 1552
companies
in the Chemicals industry
Industry Median: 59.645
vs BOM:500201: 122.49
India Glycols's Days Payable
declined
from Mar. 2025 (182.67) to Mar. 2026 (118.45).
It may suggest that India Glycolsaccelerated paying its suppliers.
India Glycols Days Payable Related Terms
India Glycols Days Payable Historical Data
* Premium members only.
The historical data trend for India Glycols's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, India Glycols's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Days Payable distribution charts can be found below:
* The bar in red indicates where India Glycols's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
India Glycols's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols (BOM:500201) has a Days Payable of 118.45 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on India Glycols and its competitors. This is 15% below median its historical median of 140.08. Over the past decade, India Glycols' Days Payable has ranged from 118.57 to 169.68. According to the industry distribution chart, India Glycols ranks #263 out of 1552 companies in the Chemicals industry, placing it in the top 16.9%.
Is India Glycols' Days Payable too high?
India Glycols' current Days Payable of 118.45 is 15% below median its 10-year median of 140.08. Over the past 10 years, this metric has ranged from a low of 118.57 to a high of 169.68. The Chemicals industry median Days Payable is 59.65. India Glycols' value of 118.45 is 98.6% above this industry median. Based on the distribution chart, India Glycols ranks #263 out of 1552 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, India Glycols has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Days Payable compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #263 out of 1552 companies for Days Payable. This places India Glycols in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 59.65. India Glycols' value of 118.45 is 98.6% above this benchmark. Historically, India Glycols' own Days Payable has ranged from 118.57 to 169.68 over the past decade. While the company's 10-year median is 140.08 vs. the industry median of 59.65, India Glycols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.65, based on 1,552 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current Days Payable of 118.45 is 98.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on India Glycols and its competitors. For the Chemicals industry, the median Days Payable is 59.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current Days Payable is 118.45, which is 15% below median its own 10-year median of 140.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹755.34, compared to a current price of ₹1,067.25 — trading 41.3% above its estimated fair value. The current Days Payable is 118.45, which is 15% below median its 10-year median of 140.08 and 98.6% above the Chemicals industry median of 59.65. India Glycols' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Days Payable is 118.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,067.25 is trading 41.3% above its estimated GF Value™ of ₹755.34.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
Days Payable: 118.45 (15% below median its 10-year median of 140.08)
GF Value™: ₹755.34 vs. price of ₹1,067.25 (41.3% above fair value)
Industry Position: 98.6% above the Chemicals median (#263 of 1552)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
71GF Score
Get the complete analysis for BOM:500201
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
